ATE402942T1 - Verfahren zur reduzierung des eisengehalts bei risedronat natrium - Google Patents

Verfahren zur reduzierung des eisengehalts bei risedronat natrium

Info

Publication number
ATE402942T1
ATE402942T1 AT04702936T AT04702936T ATE402942T1 AT E402942 T1 ATE402942 T1 AT E402942T1 AT 04702936 T AT04702936 T AT 04702936T AT 04702936 T AT04702936 T AT 04702936T AT E402942 T1 ATE402942 T1 AT E402942T1
Authority
AT
Austria
Prior art keywords
risedronate sodium
iron content
reducing iron
iron
sodium
Prior art date
Application number
AT04702936T
Other languages
English (en)
Inventor
Revital Lifshitz-Liron
Rami Lidor-Hadas
Nissm Sasson
Igor Lifshitz
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Application granted granted Critical
Publication of ATE402942T1 publication Critical patent/ATE402942T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/59—Hydrogenated pyridine rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacture Of Iron (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Manufacture And Refinement Of Metals (AREA)
AT04702936T 2003-01-17 2004-01-16 Verfahren zur reduzierung des eisengehalts bei risedronat natrium ATE402942T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44106203P 2003-01-17 2003-01-17
US44513903P 2003-02-05 2003-02-05

Publications (1)

Publication Number Publication Date
ATE402942T1 true ATE402942T1 (de) 2008-08-15

Family

ID=32776044

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04702936T ATE402942T1 (de) 2003-01-17 2004-01-16 Verfahren zur reduzierung des eisengehalts bei risedronat natrium

Country Status (11)

Country Link
US (1) US7358360B2 (de)
EP (1) EP1583768B1 (de)
JP (2) JP3869456B2 (de)
AT (1) ATE402942T1 (de)
CA (1) CA2513543A1 (de)
DE (1) DE602004015407D1 (de)
ES (1) ES2311142T3 (de)
IL (1) IL169569A (de)
PL (1) PL377878A1 (de)
PT (1) PT1583768E (de)
WO (1) WO2004065397A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0300227A2 (hu) * 2003-01-28 2004-09-28 Richter Gedeon Vegyészeti Gyár Rt. Eljárás nagy tisztaságú 2-szubsztituált -1-(hidroxi-etilidén)-1,1-biszfoszfonsavak és sóik előállítására
US7645459B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of bisphosphonates
US20080286359A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US20080287400A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7645460B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of risedronate
WO2006129056A2 (en) * 2005-05-28 2006-12-07 Pliva Hrvatska D.O.O Process and novel salt
JP5354858B2 (ja) * 2006-05-09 2013-11-27 株式会社Ａｄｅｋａ スルホンアミド化合物の金属塩を含有するポリエステル樹脂組成物
JP2009536639A (ja) 2006-05-11 2009-10-15 アイエヌディー−スイフト ラボラトリーズ リミテッド 純リセドロン酸または塩を調製するための方法
WO2009050731A2 (en) * 2007-06-20 2009-04-23 Alkem Laboratories Ltd Novel process for preparing risedronic acid

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3623397A1 (de) * 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
SE9901272D0 (sv) * 1999-04-09 1999-04-09 Astra Ab New improved formulation
US6677320B2 (en) * 2000-01-20 2004-01-13 Hoffmann-La Roches Inc. Parenteral bisphosphonate composition with improved local tolerance
US6410520B2 (en) * 2000-02-01 2002-06-25 The Procter & Gamble Company Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate
US20030195170A1 (en) * 2002-04-11 2003-10-16 Judith Aronhime Novel polymorphs and pseudopolymorphs of risedronate sodium
US7645460B2 (en) * 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of risedronate

Also Published As

Publication number Publication date
EP1583768A1 (de) 2005-10-12
CA2513543A1 (en) 2004-08-05
JP2006515867A (ja) 2006-06-08
WO2004065397A1 (en) 2004-08-05
DE602004015407D1 (de) 2008-09-11
PT1583768E (pt) 2008-09-11
EP1583768B1 (de) 2008-07-30
IL169569A (en) 2010-04-29
ES2311142T3 (es) 2009-02-01
US20040192655A1 (en) 2004-09-30
PL377878A1 (pl) 2006-02-20
US7358360B2 (en) 2008-04-15
JP2007008956A (ja) 2007-01-18
JP3869456B2 (ja) 2007-01-17

Similar Documents

Publication Publication Date Title
MY164311A (en) Process to remove impurities from triacylglycerol oil
DE602004015407D1 (de) Verfahren zur reduzierung des eisengehalts bei risedronat natrium
ATE527218T1 (de) Verfahren zur hemmung der korrosion
ATE412443T1 (de) Vorrichtung zur reduzierung des mineralgehaltes einer zone von nicht-intimen vaskulärem gewebe
ZA200903305B (en) Concentrated Surfactant Compositions
DE602005014147D1 (de) Verfahren zur herstellung von hydrokolloiden
SG154438A1 (en) Cleaning compound and method and system for using the cleaning compound
MX2009006256A (es) Composiciones intensificadoras inhibidoras de corrosion y metodos relacionados.
PL2262751T3 (pl) Zastosowanie kwasu alkanosulfonowego jako środka oczyszczającego z cementów, zapraw i betonów
MX341064B (es) Variantes de la familia il-1.
SG133499A1 (en) Cleaning compound and method and system for using the cleaning compound
EP1298205A4 (de) Neuartige lipase
MY148921A (en) Enzymatic oil interesterification
DE602006019562D1 (de) Verfahren zur hydrolyse von polyphosphorsäure in polyareneazolfasern
MX2011007188A (es) Metodos para incrementar niveles de plasmalogenos endogenos.
TW200640496A (en) Visco-supplement composition and methods
DE602006008770D1 (de) Verfahren zur hydrolyse von polyphosphorsäure in geformten artikeln
ATE486116T1 (de) Verfahren zur verschiebung von sauergasanteilen innerhalb eines erdgasnetzwerkes
MY145842A (en) Method of producing triethanolamine
MX2009006464A (es) Generacion de plantas con contenido de aceite, proteina o fibra alterado.
ATE463468T1 (de) Verwendung von magnesiumphosphat zur wasserenthärtung
MXPA05010837A (es) Aditivo para reducir la contraccion para composiciones de cemento.
ATE365759T1 (de) Verfahren zur isolierung von polyorganosiloxanen
WO2007122395A3 (en) Compositions comprising maltodextrin and associated methods
SG136026A1 (en) Oil extraction

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties